Legence Corp. (LGN): What to Watch in the Q1 2026 Earnings Report
Key Takeaways
- Analysts expect Q1 2026 revenue of approximately $930 million, aligning closely with company's guidance of $925–$950 million.
- Consensus EPS estimate stands at $0.17, with focus on path to profitability after Q4 2025 net loss of $0.55 per share.
- Company guided Q1 adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) at $90–$100 million, implying margins of about 9.5%–10.8%.
- Record backlog of $3.7 billion from Q4 supports growth, driven by data centers, government, and healthcare sectors.
- Full-year 2026 guidance raised to $3.7–$3.9 billion in revenue and $400–$430 million adjusted EBITDA.
- Stock up over 270% in the past year amid strong revenue trends, but trading near highs ahead of earnings.
Earnings Context and Why It Matters
As we approach Legence Corp. (LGN)'s Q1 2026 earnings report, due before market open on May 14, 2026, I'm paying close attention to this leading provider of engineering, installation, and maintenance services for mission-critical building systems. The company delivered impressive Q4 2025 results, with revenue surging 34.6% year-over-year to $737.6 million, driven by organic growth in data centers and technology sectors. Even with a net loss, adjusted EBITDA climbed 53% to $87 million, and the backlog reached a record $3.7 billion. From what I see, investors are focused on Legence's strong positioning in high-growth areas like data center cooling, especially with rising AI demand in a competitive construction landscape. This report will be key in assessing whether that momentum holds, particularly as the company navigates profitability recovery against labor and supply chain challenges.
Earnings Expectations
Wall Street's consensus points to Q1 2026 revenue of $930.48 million, drawn from 12 analysts, which sits comfortably within Legence's own guidance of $925–$950 million. The EPS estimate comes in at $0.17 from eight analysts, marking a recovery from Q4's $(0.55) GAAP loss, influenced in part by one-time items such as stock-based compensation. Management has guided for adjusted EBITDA of $90–$100 million, incorporating a full quarter from recent acquisitions like Bowers + Kubota and a partial contribution from Metrix.
One thing that stands out are the key metrics to monitor: gross margins (adjusted at 21.2% in Q4), book-to-bill (1.9x in Q4), and backlog conversion. Legence has a track record of beating revenue estimates—Q4 saw a 19% surprise—though EPS has sometimes missed due to non-cash charges. Post-earnings stock reactions have typically favored top-line strength, with shares rallying even amid losses, highlighting the market's emphasis on growth.
Market Reaction and Investor Sentiment
Sentiment heading into these earnings feels cautiously optimistic. Shares are up 2.5% lately, trading around $99.89 near 52-week highs, which reflects trust in the company's guidance and backlog. That said, risks like margin pressure from labor costs or acquisition integration linger, along with the Q4 EPS miss that expanded losses. Options flow and volume indicate some positioning for a revenue beat, though volatility could rise if profitability disappoints. The broader industrials sector's resilience adds to the upside case.
Why I Rely on Tickeron’s AI Screener
In my own analysis of stocks like LGN, I often turn to Tickeron’s AI Screener, an AI-powered tool for discovering stocks and ETFs. It lets me filter thousands of names using customizable criteria like technical patterns, fundamentals, trends, volatility, and AI signals—covering industry, market cap, indicators, price patterns, and performance metrics. This helps pinpoint trade ideas, trending stocks, breakouts, and opportunities far more efficiently than manual scans, and it's become a staple in how I evaluate peers and sector positioning.
Forward Outlook and Key Factors to Monitor
Legence has raised its full-year 2026 guidance to $3.7–$3.9 billion in revenue and $400–$430 million in adjusted EBITDA, pointing to 42%–52% EBITDA growth supported by the $3.7 billion backlog, up 49% year-over-year. Demand from data centers & technology, state/local government, and life sciences/healthcare remains robust, with book-to-bill ratios above 1x indicating ongoing contract wins.
After earnings, I'll be watching for updates to guidance amid macro pressures like interest rates impacting construction. Integration of acquisitions—such as the full-quarter effect from Bowers—and CapEx around $65 million for capacity expansion will matter. Cash taxes in the low-$30 million range and an effective tax rate in the mid-30s%–40% will shape free cash flow prospects.
Industry headwinds persist, including skilled labor shortages and supply chain issues for mission-critical systems. Strong demand from hyperscalers for cooling solutions could speed up backlog conversion—over half expected in 2026—and balanced execution will be crucial for multi-year growth. I'm watching this closely as it unfolds.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
LGN's Indicator enters downward trend
The Aroon Indicator for LGN entered a downward trend on August 07, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 4 similar instances where the Aroon Indicator formed such a pattern. In of the 4 cases the stock moved lower. This puts the odds of a downward move at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on August 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LGN as a result. In of 15 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for LGN turned negative on August 21, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 7 similar instances when the indicator turned negative. In of the 7 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LGN advanced for three days, in of 63 cases, the price rose further within the following month. The odds of a continued upward trend are .
LGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. LGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.605) is normal, around the industry mean (17.590). P/E Ratio (123.451) is within average values for comparable stocks, (221.246). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.057). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (1.219) is also within normal values, averaging (3.226).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
Advertisement